Joshua E. Freeman

Array ( [id] => 159791 [patent_doc_number] => 07674935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Crystal forms of O-desmethylvenlafaxine' [patent_app_type] => utility [patent_app_number] => 11/788034 [patent_app_country] => US [patent_app_date] => 2007-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4452 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674935.pdf [firstpage_image] =>[orig_patent_app_number] => 11788034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4803670 [patent_doc_number] => 20080015259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Substantially pure O-desmethylvenlafaxine and processes for preparing it' [patent_app_type] => utility [patent_app_number] => 11/788030 [patent_app_country] => US [patent_app_date] => 2007-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7673 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015259.pdf [firstpage_image] =>[orig_patent_app_number] => 11788030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771410 [patent_doc_number] => 20080057068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'SARMS and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/785250 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 58770 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057068.pdf [firstpage_image] =>[orig_patent_app_number] => 11785250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046622 [patent_doc_number] => 20070265296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Nuclear receptor binding agents' [patent_app_type] => utility [patent_app_number] => 11/785251 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 82832 [patent_no_of_claims] => 181 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265296.pdf [firstpage_image] =>[orig_patent_app_number] => 11785251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670470 [patent_doc_number] => 20080045530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Organic Compounds and Their Uses' [patent_app_type] => utility [patent_app_number] => 11/697889 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45397 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045530.pdf [firstpage_image] =>[orig_patent_app_number] => 11697889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576109 [patent_doc_number] => 20090143471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Process for the Atomization of Ioxilan' [patent_app_type] => utility [patent_app_number] => 12/226063 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3174 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143471.pdf [firstpage_image] =>[orig_patent_app_number] => 12226063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292546 [patent_doc_number] => 07544839 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Process for the synthesis and crystalline form agomelatine' [patent_app_type] => utility [patent_app_number] => 11/784484 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3756 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544839.pdf [firstpage_image] =>[orig_patent_app_number] => 11784484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84217 [patent_doc_number] => 07741509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Conversion of terephthalic acid to Di-n-butyl terephthalate' [patent_app_type] => utility [patent_app_number] => 11/732236 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7216 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741509.pdf [firstpage_image] =>[orig_patent_app_number] => 11732236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840595 [patent_doc_number] => 07390925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Oxime-containing acyl guanidines as beta-secretase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/693026 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12359 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390925.pdf [firstpage_image] =>[orig_patent_app_number] => 11693026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823839 [patent_doc_number] => 07405311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states' [patent_app_type] => utility [patent_app_number] => 11/729101 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7512 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405311.pdf [firstpage_image] =>[orig_patent_app_number] => 11729101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5066746 [patent_doc_number] => 20070187847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Process for the preparation of pure aryllithium compounds and their use' [patent_app_type] => utility [patent_app_number] => 11/725614 [patent_app_country] => US [patent_app_date] => 2007-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4306 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20070187847.pdf [firstpage_image] =>[orig_patent_app_number] => 11725614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820656 [patent_doc_number] => 07407989 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Compounds useful for modulating abnormal cell proliferation' [patent_app_type] => utility [patent_app_number] => 11/723261 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6384 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407989.pdf [firstpage_image] =>[orig_patent_app_number] => 11723261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4535385 [patent_doc_number] => 07872153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Salt of aliskiren with sulfuric acid' [patent_app_type] => utility [patent_app_number] => 12/293162 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7707 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872153.pdf [firstpage_image] =>[orig_patent_app_number] => 12293162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404627 [patent_doc_number] => 20090239941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'AMINO ACID DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/282913 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8751 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239941.pdf [firstpage_image] =>[orig_patent_app_number] => 12282913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324575 [patent_doc_number] => 20090062565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Continuous Process for the Production of mono- or dicarboxylic acid alkyl amides' [patent_app_type] => utility [patent_app_number] => 12/293509 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1536 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062565.pdf [firstpage_image] =>[orig_patent_app_number] => 12293509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515551 [patent_doc_number] => 08039623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Inhibitors of serine proteases, particularly HCV NS3-NS4A protease' [patent_app_type] => utility [patent_app_number] => 11/716248 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20902 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039623.pdf [firstpage_image] =>[orig_patent_app_number] => 11716248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585907 [patent_doc_number] => 07446225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds' [patent_app_type] => utility [patent_app_number] => 11/684355 [patent_app_country] => US [patent_app_date] => 2007-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10017 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446225.pdf [firstpage_image] =>[orig_patent_app_number] => 11684355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063811 [patent_doc_number] => 20070225451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Biuret compounds for rheology control' [patent_app_type] => utility [patent_app_number] => 11/714687 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5205 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225451.pdf [firstpage_image] =>[orig_patent_app_number] => 11714687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304444 [patent_doc_number] => 20090299096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Amidoadamantanes and Method for Producing the Same' [patent_app_type] => utility [patent_app_number] => 12/224545 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2269 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20090299096.pdf [firstpage_image] =>[orig_patent_app_number] => 12224545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8017743 [patent_doc_number] => 08138375 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Method for producing 1-formamido-3,5-dimethyladamantane' [patent_app_type] => utility [patent_app_number] => 12/224575 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1132 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/138/08138375.pdf [firstpage_image] =>[orig_patent_app_number] => 12224575 [rel_patent_id] =>[rel_patent_doc_number] =>)